awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33367606-4281905A-7619-4594-AAB8-D4F3F9FF279D
Q33367606-4281905A-7619-4594-AAB8-D4F3F9FF279D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33367606-4281905A-7619-4594-AAB8-D4F3F9FF279D
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients.
P2860
Q33367606-4281905A-7619-4594-AAB8-D4F3F9FF279D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33367606-4281905A-7619-4594-AAB8-D4F3F9FF279D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91083ec2225bf5fc9e4697be613c7f30504ee508
P2860
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I